We have located links that may give you full text access.
Recent Improvements in Attainment of the Hemoglobin A1c Target of ≤7.0% among Adults with Type 1 Diabetes in Ontario: A Retrospective Cohort Study.
Diabetes Technology & Therapeutics 2024 March 26
Aims We evaluated attainment of the HbA1c target of ≤7.0%, its temporal trends, and associated factors among adults with type 1 diabetes in Ontario, Canada using administrative data. Methods We conducted a retrospective cohort study including Ontarians with type 1 diabetes ≥18 years old with ≥1 HbA1c test between April 1, 2012 (fiscal year 2013) and March 31, 2023. Generalized estimating equations were used to determine probabilities of meeting the HbA1c target, as well as associations between fiscal year and individual-, physician-, and system-level factors on odds of meeting the target. Results Among 28,827 adults with type 1 diabetes [14,385 (49.9%) female, 17,998 (62.4%) pump users] with median age at index of 25 years [interquartile range (IQR) 18-37] and median diabetes duration 12 years [6-18], there were 474,714 HbA1c tests (median 2/individual/year (IQR 1-3)). The model-estimated probability of meeting the HbA1c target of ≤7.0% was 22.1% (95% CI 21.6-22.5%) in 2013, remained stable until 2020, and increased to 34.7% (95% CI 34.3 to 35.2%) in 2023. The age- and sex- adjusted odds ratio for meeting the target in 2023 vs. 2013 was 1.87 (95% CI 1.79-1.96). Young adults (18-25 years), diabetic ketoacidosis, greater comorbidity and receiving diabetes care from a non-specialist physician were associated with reduced odds of meeting the HbA1c target. Conclusions One-third of adults with type 1 diabetes in Ontario met the recommended HbA1c target of ≤7.0% in 2023, with improvement noted since 2021 which may be due to advanced technologies or effects of the COVID-19 pandemic.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Revascularization Strategy in Myocardial Infarction with Multivessel Disease.Journal of Clinical Medicine 2024 March 27
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app